Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
WADA 2026 Prohibited List Status (Section S0) Retatrutide is not currently named explicitly on the World Anti-Doping Agency 2025 or 2026 Prohibited Lists but falls within section S0 (Non-Approved Substances), which covers any pharmacological substance not currently approved by a governmental health authority for human therapeutic use
UK researchers sourcing BPC-157 should look for a supplier with verifiable third-party COAs, batch traceability and UK cold-chain handling
Make sure you have a valid prescription from your doctor
PMID: 20225319
Journal (Journal of Physiology and Pharmacology, Dec 2009, 60 Suppl 7, 191196)
Improving protocols for PRP preparation and administration in patellar tendinopathy A major challenge in studying the efficacy of PRP in patellar tendinopathy is the lack of standardized protocols for preparing and administering PRP and the absence of protocol regarding uniformity on the correct amount and number of dosages
